Log In
Log In
Client Account Access
Equity Research Access
Financial Strategies Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about Immunovant-2023-09-27
$322.0 Million
Image
Immunovant, Inc.
Follow-On Offering
PIPE
Active Bookrunner
Read more
about CymaBay-2023-09-13
$258.7 Million
Image
CymaBay Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about Crinetics-2023-09-12
$350.0 Million
Image
Crinetics Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about Biohaven Ltd.-2023-10-02
$258.7 Million
Image
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ALX Oncology-2023-10-04
$63.2 Million
Image
ALX Oncology
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Natera-2023-09-06
$250.3 Million
Image
Natera, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Arhaus-2023-08-16
$138.0 Million
Image
Arhaus, LLC
Follow-On Offering
Active Bookrunner
Read more
about Inozyme-2023-07-27
$60.0 Million
Image
Inozyme Pharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Procept-2023-08-01
$149.9 Million
Image
Procept Biorobotics Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about SagimetBiosciences-2023-07-13
$85.0 Million
Image
Sagimet Biosciences
Initial Public Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 2
Next page
››
Subscribe to Active Bookrunner
